Heart Failure Performance Measures
Heart failure, also called congestive heart failure, is a condition in which the heart cannot pump enough oxygenated blood to meet the needs of the body's other organs. The heart keeps pumping, but not as efficiently as a healthy heart. Usually, the loss in the heart's pumping action is a symptom of an underlying heart problem. Heart failure affects nearly 5 million US adults. It is on the rise with an estimated 400,000 to 700,000 new cases each year.
The following graph shows how MUSC performed on three key measures related to care for patients being treated for heart failure. Each measure represents what percentage of the time patients received the recommended care, so a higher score represents better performance. The numbers reported are from October - December 2013.
Appropriate Care Measure
Where to go for more information:
- Heart and Vascular Center
- Listen to Heart and Vascular Health audio podcasts
- Watch Heart and Vascular Health videos
Discharge Instructions -Heart failure patients discharged home with written discharge instructions or educational material given to patient or caregiver at discharge or during the hospital stay addressing all of the following:
- activity level
- discharge medications
- follow-up appointment
- weight monitoring
- what to do if symptoms worsen *
Heart failure patients with documentation in the hospital record that left ventricular function (LVF) was assessed before arrival, during hospitalization, or is planned for after discharge. Appropriate selection of medications to reduce morbidity and mortality in heart failure requires the identification of patients with impaired left ventricular systolic function. *
ACE inhibitors and ARBs are medications used to treat heart attacks, and if taken within 24 hours of heart attack symptoms, they greatly reduce the risk of death. For purposes of this measure, LVSD is defined as chart documentation of a left ventricular ejection fraction (LVEF) less than 40% or a narrative description of left ventricular function (LVF) consistent with moderate or severe systolic dysfunction. ACEI therapy reduces mortality and morbidity in patients with heart failure and left ventricular systolic dysfunction and is effective in a wide range of patients. *
*Source: The Centers for Medicare & Medicaid Services and the Joint Commission "Specifications Manual for National Hospital Quality Measures."